Summary Comments
- Most frequently detected viruses in June 2023 (all age groups):
- Influenza A: 29.3%
- Rhino/Enterovirus: 23.6%
- Rhinovirus: 20.5%
- Epidemiological Week 1–26:
- SARS-CoV-2: Stable at ~4% in week 26
- RSV A&B: Stable, 5.4% in week 26
- Influenza A: Declining from week 22 onward; 13.8% in week 26
Respiratory Viral Multiplex PCR and SARS-CoV-2 PCR: All Age Groups
May 2023:
- Influenza A: 37.7%
- Rhino/Enterovirus: 29.1%
- Rhinovirus: 22.4%
- SARS-CoV-2: 6.5%
- RSV A&B: 9.29%
- Adenovirus: 4.2%
- Parainfluenza 1–4: 6.8%
- Metapneumovirus: 6.9%
- Coronavirus (non-SARS-CoV-2): 3.2%
- Influenza B: 0.1%
June 2023:
- Influenza A: 29.3%
- Rhino/Enterovirus: 23.6%
- Rhinovirus: 20.5%
- SARS-CoV-2: 4.0%
- RSV A&B: 4.5%
- Adenovirus: 4.2%
- Parainfluenza 1–4: 5.4%
- Metapneumovirus: 6.8%
- Coronavirus (non-SARS-CoV-2): 3.2%
- Influenza B: 0.1%
COVID-19, Influenza A & RSV Positivity by Week (Weeks 1–26)
- COVID-19: Stable at 4% in week 26
- Influenza A: Dropped to 13.8% in week 26 (from 45.4% peak)
- RSV A&B: At 5.4% in week 26
Atypical Bacterial Pathogens
Cases (Weeks 1–26):
- B. pertussis: 312
- B. parapertussis: 23
- M. pneumoniae: 805 (peak: 72 cases in week 25)
Age Distribution – B. pertussis:
- 0–6 months: 25%
- 6–12 years: 22%
- 1–5 years: 21%
18 years: 21%
Age Distribution – M. pneumoniae:
- 1–5 years: 41%
- 6–12 years: 28%
- 19–64 years: 14%
B. pertussis (weeks 1–26):
8, 7, 5, 16, 13, 4, 6, 8, 9, 9, 7, 11, 16, 10, 15, 19, 13, 13, 17, 9, 13, 23, 21, 11, 16, 13
B. parapertussis (weeks 1–26):
0, 1, 0, 2, 3, 2, 2, 1, 0, 1, 2, 2, 1, 0, 2, 0, 1, 0, 0, 1, 0, 0, 0, 0, 1, 1
M. pneumoniae (weeks 1–26):
4, 6, 10, 7, 5, 11, 12, 17, 12, 18, 25, 30, 23, 34, 37, 36, 34, 42, 42, 52, 46, 63, 62, 57, 72, 48
Paediatric Respiratory Viral Multiplex PCR Data (Ages 0–12)
<1 Year Age Group
May 2023:
- Rhino/Enterovirus: 44.3%
- Rhinovirus: 35.9%
- RSV A&B: 23.5%
- Influenza A: 12.7%
- SARS-CoV-2: 9.1%
- Parainfluenza 1–4: 6.8%
- Adenovirus: 4.9%
- Metapneumovirus: 6.0%
- Influenza B: 0.1%
June 2023:
- Rhino/Enterovirus: 37.3%
- Rhinovirus: 35.8%
- RSV A&B: 13.9%
- Influenza A: 13.5%
- SARS-CoV-2: 9.9%
- Parainfluenza 1–4: 4.7%
- Adenovirus: 3.4%
- Metapneumovirus: 6.4%
- Influenza B: 0%
1–5 Year Age Group
May 2023:
- Rhino/Enterovirus: 41.9%
- Rhinovirus: 33.4%
- RSV A&B: 9.4%
- Influenza A: 10.4%
- SARS-CoV-2: 14.3%
- Parainfluenza 1–4: 11.0%
- Adenovirus: 7.6%
- Metapneumovirus: 8.2%
- Influenza B: 0.1%
June 2023:
- Rhino/Enterovirus: 39.0%
- Rhinovirus: 30.3%
- RSV A&B: 6.3%
- Influenza A: 32.9%
- SARS-CoV-2: 15.2%
- Parainfluenza 1–4: 4.3%
- Adenovirus: 7.5%
- Metapneumovirus: 10.4%
- Influenza B: 0%
6–12 Year Age Group
May 2023:
- Influenza A: 54.5%
- Rhino/Enterovirus: 29.3%
- Rhinovirus: 19.3%
- SARS-CoV-2: 5.7%
- RSV A&B: 1.8%
- Adenovirus: 2.2%
- Parainfluenza 1–4: 1.4%
- Metapneumovirus: 2.1%
- Influenza B: 0.2%
June 2023:
- Influenza A: 41.7%
- Rhino/Enterovirus: 24.5%
- Rhinovirus: 15.4%
- SARS-CoV-2: 5.5%
- RSV A&B: 2.4%
- Adenovirus: 3.5%
- Parainfluenza 1–4: 1.2%
- Metapneumovirus: 3.7%
- Influenza B: 0.2%
Continue Reading